… In summary, as little as a 200-mg daily dose of modafinil is an effective and well-tolerated
treatment of EDS in patients with narcolepsy. The long-term effectiveness is under evaluation. …

… found with modafinil (all p > 0.05). There was a significant reduction in CPAP use … modafinil
compared to placebo (6.3 ± 1 h/ night; 6.5 ± 1, p = 0.03). This study suggests that modafinil …

… Objectives: Modafinil has recently been approved for the treatment of shift work sleep …
Study Design This was a randomized, double-blind, placebo-controlled crossover study. We …

… In this study, we evaluated the effect of modafinil for treatment of daytime sleepiness in PD
patients. The ESS significantly improved with modafinil compared to placebo, whereas the …

… -reported fatigue on the MFI after 6 weeks of modafinil treatment with a type I error rate of 0.05
… required for a crossover study using previously reported effects of modafinil on fatigue for …

… We therefore designed a double-blind crossover study (modafinil versus placebo) to test the
… In conclusion, patients with hypersomnia treated with modafinil should be considered to be …

… study was to determine how treatment with modafinil … , randomized, crossover, inpatient trial
of modafinil (400 mg daily) versus placebo with 4-day washout period between 2 treatments. …

… . Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized
crossover double-blind placebo-controlled trial. Am J Respir Crit Care Med 2010;181:825–…

… Modafinil treatment reduced steering variability and the mean RT to DA probes on the …
In this randomized placebo-controlled crossover trial, we show for the first time that modafinil …

… double-blind, randomized, crossover study, patients and controls received a single dose of
400 mg modafinil … Modafinil is a first-line pharmacological treatment for daytime sleepiness in …